NABL, CAP, ISO
Overview of Creatinine - Spot
What is Creatinine - Spot?
It is done to evaluate the health of your kidneys. It can be done as a part of basic metabolic panel or when you have signs or symptoms suggestive of kidney disease like swelling of face, ankle, lower back pain, changes in urine output etc. It should also be done to monitor the treatment if you are already diagnosed with a kidney disease. It is also ordered if you have diseases which can affect the kidney like diabetes etc.
Why is Creatinine - Spot done?
- As a part of routine health check up or basic metabolic panel
- As a part of kidney function test
- If you have signs or symptoms of kidney disease like swelling or puffiness around the eyes, face, wrists etc, poor appetite, change in urinary frequency, bloody urine, mid back pain or high blood pressure
- If you already have a kidney disease, this test is regolarly done to assess the function of your kidneys and plan further management
Preparation for Creatinine - Spot
- No special preparation required
Sample Type for Creatinine - Spot
The sample type collected for Creatinine - Spot is: Urine
Interpreting Creatinine - Spot results
- Increased creatinine levels in blood suggest kidney disease or other disorders which may affect kidney function. These include: damage to the blood vessels in kidney (glomerulonephritis), bacterial infection of kidney (pyelonephritis), acute tubular necrosis, kidney stones or rarely congestive heart failure, dehydration etc
- Low levels of creatinine are not usually seen and is not a cause for concern
Answers to Patient Concerns & Frequently Asked Questions (FAQs) about Creatinine - Spot
Frequently Asked Questions about Creatinine - Spot
Q. Does exercise affect my creatinine levels?
Moderate exercise does not usually affect the creatinine levels. As you continue exercising, more muscle mass is built which may affect the levels temporarily.
Q. Does diet affect the levels of creatinine?
Some studies suggest that eating cooked meat prior to the test may increase the levels.
With a decade of experience under its belt, Oncquest is known for its excellence in Clinical Diagnostics. From its first avatar as an R&D focused entity, Oncquest has evolved into a reference laboratory in the field of Oncology, and more recently into a multi-platform Pathology Services provider with a core focus in Molecular Pathology and Surgical Pathology Services. Its logistic capabilities and geographical spread makes Oncquest an ideal associate for clinical activities in India. Oncquest’s accredited quality systems ensure customer satisfaction through any of its customer-centric service offerings. Oncquest’s recent advances in the areas of Companion Diagnostics and Pharmacogenomics have also allowed for and encouraged greater penetration of Personalized Medicine into the Indian healthcare market, making it the future epicentre of the many technological advancements in healthcare, to come. Its close association with many Hospitals across India stands testament to the faith that Oncquest has instilled in the doctors and patients which avail of its services. Oncquest is fast becoming a cornerstone for a blooming healthcare industry. With over a decade of experience in the field of molecular diagnostics and pathology services, Oncquest Laboratories has earned its reputation of clinical excellence in the Indian market. Our advanced technologies and global quality systems have ensured that we stay ahead of the curve, and this has resulted in our association with some of the most advanced clinicians, hospitals and research organizations in the country. As India gets set for a clinical revolution, ushering in a trend of new healthcare services and products, Oncquest has defined its place as a partner of choice for those who bring value to our proud subcontinent. Our national reach and sizeable knowledge base allows us to be at the forefront of scientific advances, and an ideal partner for clinical activities. We strive to be connected with the best in the industry and we welcome partnership in ideas and technologies. For example, Oncquest’s early adoption and utilization of genetic sequencing technologies has resulted in many “first to market” assays, which have subsequently been adopted in several treatment and monitoring protocols. Innovation is an essential part of our DNA. We welcome challenges, and look forward to associating with you and your organizations to develop pioneering solutions and to tackle some of the most pressing issues faced in our world.